Finance

Beta
Lists
DKNG:NASDAQ
DraftKings Inc
$25.52
-0.53%
(-0.14) 1D
Jun 23, 10:09:37 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DKNG...
Open
$25.43
High
$25.81
Low
$25.42
Mkt. cap
12.63B
Avg. vol.
13.38M
Volume
906.09K
P/E ratio
263.10
52-wk high
$48.78
52-wk low
$20.46
EPS
$0.10
Beta
1.66
Shares outstanding
496.13M
No. of employees
6K
Open
$25.43
High
$25.81
Low
$25.42
Mkt. cap
12.63B
Avg. vol.
13.38M
Volume
906.09K
P/E ratio
263.10
52-wk high
$48.78
52-wk low
$20.46
EPS
$0.10
Beta
1.66
Shares outstanding
496.13M
No. of employees
6K
News stories
From sources across the web
About DraftKings Inc
CEO-
Employees5.5K
Founded2011
HeadquartersBoston, Massachusetts, United States
SectorCasino
Websitedraftkings.com
Analyst Ratings
Based on 27 analysts giving stock ratings to DKNG in the past 3 months
Strong Buy
Buy
23
Hold
3
Sell
1
12 month forecast
Based on 27 Wall Street analysts offering 12 month price targets for DKNG in the last 3 months.
Highest
Current $25.52
$50.00 (+95.96%)
Average
$35.57 (+39.41%)
Lowest
$27.00 (+5.82%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Ian S. Moore
Bernstein
Buy
Maintained
$31.00
+21.5%
06/17/2026
Ryan Sigdahl
Craig-Hallum
Buy
Reiterated
$31.00
+21.5%
06/16/2026
Trey Bowers
Wells Fargo
Buy
Reiterated
$32.00
+25.4%
06/12/2026
Jed Kelly
Oppenheimer
Buy
Reiterated
$35.00
+37.2%
06/11/2026
Daniel Politzer
J.P. Morgan
Buy
Maintained
-
-
06/10/2026
David Katz
Jefferies
Buy
Maintained
$46.00
+80.3%
06/10/2026
Stephen Grambling
Morgan Stanley
Buy
Maintained
$39.00
+52.9%
06/09/2026
Robin M. Farley
UBS
Buy
Reiterated
$49.00
+92%
06/08/2026
Lance Vitanza
TD Cowen
Buy
Maintained
$30.00
+17.6%
06/08/2026
Nick McKay
Freedom Capital Markets
Buy
Initiated
$30.00
+17.6%
05/21/2026
Unknown Analyst
Exane BNP Paribas
Sell
Downgraded
-
-
05/14/2026
Barry Jonas
Truist Financial
Buy
Reiterated
-
-
05/12/2026
Benjamin Chaiken
Mizuho Securities
Buy
Maintained
$45.00
+76.4%
05/12/2026
James Hardiman
Citi
Buy
Reiterated
$30.00
+17.6%
05/12/2026
Greg Gibas
Northland Securities
Hold
Maintained
$27.00
+5.8%
05/11/2026
Jeffrey Stantial
Stifel Nicolaus
Buy
Reiterated
$40.00
+56.8%
05/11/2026
Brandt Montour
Barclays
Buy
Reiterated
$35.00
+37.2%
05/11/2026
Bernie McTernan
Needham
Buy
Reiterated
$35.00
+37.2%
05/11/2026
Matthew Weber
Canaccord Genuity
Buy
Maintained
$44.00
+72.4%
05/11/2026
Clark Lampen
BTIG
Buy
Maintained
$30.00
+17.6%
05/08/2026
Brian Pitz
BMO Capital
Buy
Reiterated
$50.00
+96%
05/08/2026
Michael Graham
Canaccord Genuity
Buy
Maintained
$44.00
+72.4%
05/08/2026
Shaun Kelley
Bank of America Securities
Hold
Reiterated
$27.00
+5.8%
05/08/2026
Arpine Kocharyan
UBS
Buy
Maintained
$43.00
+68.5%
05/08/2026
Curry Baker
Guggenheim
Buy
Reiterated
$35.00
+37.2%
05/08/2026
Robert Fishman
MoffettNathanson
Hold
Downgraded
-
-
04/24/2026
Jordan Bender
Citizens JMP
Buy
Maintained
$34.00
+33.3%
04/01/2026
Joseph Stauff
Susquehanna
Buy
Reiterated
$32.00
+25.4%
03/31/2026
Eric Sheridan
Goldman Sachs
Buy
Maintained
$31.00
+21.5%
03/24/2026
John Staszak
Argus Research
Hold
Downgraded
-
-
03/17/2026
Jason Tilchen
Canaccord Genuity
Buy
Maintained
$44.00
+72.4%
03/03/2026
Jack Cummings
Berenberg Bank
Buy
Maintained
$26.40
+3.5%
02/23/2026
David Bain
Texas Capital Securities
Hold
Maintained
$27.00
+5.8%
02/18/2026
Steven Pizzella
Deutsche Bank
Hold
Maintained
$26.00
+1.9%
02/17/2026
Chad Beynon
Macquarie
Buy
Maintained
$40.00
+56.8%
02/17/2026
Mike Hickey
Benchmark Co.
Buy
Maintained
$29.00
+13.7%
02/13/2026
Andrew Tam CFA
Rothschild & Co Redburn
Hold
Maintained
$35.00
+37.2%
01/30/2026
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.20 / $0.17
+16.41%beat
Revenue / Est. (USD)
1.65B / 1.63B
+0.92%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.51B
1.14B
1.99B
1.65B
Cost of goods sold
352.63M
328.63M
404.70M
379.85M
Cost of revenue
352.63M
328.63M
404.70M
379.85M
Research and development expenses
108.42M
114.68M
133.56M
123.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
398.89M
517.15M
616.16M
567.67M
Operating expense
1.01B
1.09B
1.42B
1.26B
Total operating expenses
1.36B
1.42B
1.82B
1.64B
Operating income
150.64M
-271.89M
164.97M
5.85M
Other non operating income
-5.85M
4.23M
3.84M
-
EBT including unusual items
169.73M
-268.85M
146.58M
27.44M
EBT excluding unusual items
145.27M
-285.57M
162.94M
4.62M
Income tax expense
11.79M
-12.06M
10.15M
6.37M
Effective tax rate
6.95%
4.49%
6.92%
23.21%
Other operating expenses
501.93M
455.45M
669.81M
569.53M
Net income
157.94M
-256.79M
136.43M
21.07M
Net profit margin
10.44%
-22.45%
6.86%
1.28%
Earnings per share
0.38
-0.26
0.36
0.20
Interest and investment income
12.30M
-
-
-
Interest expense
-11.64M
-19.57M
-5.43M
-5.74M
Net interest expenses
665.00K
-19.57M
-5.43M
-5.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
215.94M
-205.82M
238.98M
77.51M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer